These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25733587)

  • 1. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
    Bastard JP; Fellahi S; Couffignal C; Raffi F; Gras G; Hardel L; Sobel A; Leport C; Fardet L; Capeau J;
    J Antimicrob Chemother; 2015; 70(6):1816-24. PubMed ID: 25733587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.
    Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; Gérard L; May T; Simon A; Vigouroux C; Goujard C;
    PLoS One; 2015; 10(12):e0144317. PubMed ID: 26636578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.
    Saracino A; Bruno G; Scudeller L; Volpe A; Caricato P; Ladisa N; Monno L; Angarano G
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1178-84. PubMed ID: 25360575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
    Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
    Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals.
    Zoufaly A; Kiepe JG; Hertling S; Hüfner A; Degen O; Feldt T; Schmiedel S; Kurowski M; van Lunzen J
    HIV Med; 2014 Sep; 15(8):449-57. PubMed ID: 24580846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy.
    Conley LJ; Bush TJ; Rupert AW; Sereti I; Patel P; Brooks JT; Baker JV;
    AIDS; 2015 Oct; 29(16):2201-7. PubMed ID: 26544583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.
    Chiappetta S; Ripa M; Galli L; Razzari C; Longo V; Galli A; Faioni EM; Nozza S; Lazzarin A; Tambussi G
    J Antimicrob Chemother; 2016 Jun; 71(6):1627-31. PubMed ID: 26888911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults.
    Zhang Z; Chew GM; Shikuma CM; Gangcuangco LMA; Souza SA; Shiramizu B; Nakamoto BK; Gong T; Mannem SR; Mitchell BI; Kallianpur KJ; Ndhlovu LC; Chow DC
    HIV Clin Trials; 2018 Oct; 19(5):172-176. PubMed ID: 30422099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
    Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
    PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
    Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
    J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment.
    Campillo-Gimenez L; Casulli S; Dudoit Y; Seang S; Carcelain G; Lambert-Niclot S; Appay V; Autran B; Tubiana R; Elbim C
    J Allergy Clin Immunol; 2014 Nov; 134(5):1142-52.e5. PubMed ID: 25042982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects.
    Wallet MA; Buford TW; Joseph AM; Sankuratri M; Leeuwenburgh C; Pahor M; Manini T; Sleasman JW; Goodenow MM
    BMC Immunol; 2015 Jul; 16():43. PubMed ID: 26204934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
    Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
    AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Hoffman RM; Lake JE; Wilhalme HM; Tseng CH; Currier JS
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):247-54. PubMed ID: 26569649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy.
    Fabre-Mersseman V; Tubiana R; Papagno L; Bayard C; Briceno O; Fastenackels S; Dudoit Y; Rostane H; Salmon D; Costagliola D; Caby F; Sauce D; Viard JP; Appay V
    AIDS; 2014 Nov; 28(18):2677-82. PubMed ID: 25493593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
    Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
    J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects.
    De Pablo-Bernal RS; Ruiz-Mateos E; Rosado I; Dominguez-Molina B; Alvarez-Ríos AI; Carrillo-Vico A; De La Rosa R; Delgado J; Muñoz-Fernández MA; Leal M; Ferrando-Martínez S
    J Antimicrob Chemother; 2014 Nov; 69(11):3041-6. PubMed ID: 25011654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.